Primary liver cancers are among the most rapidly evolving malignant tumors worldwide. An
underlying chronic inflammatory liver disease, which precedes liver cancer development for …

Hepatocellular carcinoma (HCC) is the dominant type of liver cancers and is one of the
deadliest health threats globally. The conventional therapeutic options for HCC are …

Hepatocellular carcinoma (HCC) is a complex disease with a dismal prognosis.
Consequently, a translational approach is required to personalized clinical decision making …

Primary liver cancer is the third most deadly and fifth most common cancer worldwide, with
an estimated 877,000 new cases and almost as many deaths in 2007. Hepatocellular …

In recent years, large scale genomics and genome-wide studies using comprehensive
genomic tools have reshaped our understanding of cancer evolution and heterogeneity …

Despite enthusiastic efforts using the latest advanced molecular technologies, no specific
universal genetic alteration has been found in hepatocellular carcinoma (HCC). The …

Hepatocellular carcinoma (HCC) is a deadly cancer, whose incidence is increasing
worldwide. Albeit the main risk factors for HCC development have been clearly identified …

Liver cancer is the sixth-most-common cancer overall but the third-most-frequent cause of
cancer death. Among primary liver cancers, hepatocellular carcinoma (HCC), the major …

Being one of the most lethal cancers that exhibit high levels of heterogeneity, hepatocellular
carcinoma (HCC) is associated with diverse oncogenic pathways underpinned by varied …

Over the past several years, the success of genome‐wide association studies (GWAS) and
pharmacogenomics has gradually begun to enable personalized medicine in some fields. In …